Advertisement

Picture EBD Group BIO-Europe 2018 Copenhagen Denmark Partnerships 600x60px
Document › Details

Schwarz, Diana [BioRegio STERN]. (9/18/14). "News: Interview mit Dr. Ingmar Hoerr zur Kooperation von CureVac und Boehringer Ingelheim".

Region Region Germany
Organisations Organisation Boehringer Ingelheim (Group)
  Organisation 2 CureVac GmbH
  Today CureVac AG
Products Product CV9202 mRNA cancer vaccine
  Product 2 afatinib
Index term Index term Boehringer–CureVac: RNActive vaccine, 20140901– collab developm + excl ww license for CV9202 €35m upfront + €430m milestones + royalties
Person Person Hoerr, Ingmar (CureVac 200601 CEO + co-founder)
     


   
Record changed: 2017-04-02

Advertisement

Picture Berlin Partner HealthCapital RegMed Forum 2018 October 600x60px

More documents for Boehringer Ingelheim (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group BIO-Europe 2018 Copenhagen Denmark Partnerships 600x60px




» top